{"id":70493,"date":"2026-07-23T21:25:22","date_gmt":"2026-07-23T13:25:22","guid":{"rendered":"https:\/\/flcube.com\/?p=70493"},"modified":"2026-07-23T21:25:23","modified_gmt":"2026-07-23T13:25:23","slug":"guangdong-launches-greater-bay-area-cross-border-medical-import-framework-for-hong-kong-and-macau-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=70493","title":{"rendered":"Guangdong Launches Greater Bay Area Cross-Border Medical Import Framework for Hong Kong and Macau Pharmaceuticals"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">The <strong>Guangdong Provincial Drug Administration<\/strong> and <strong>Guangdong Provincial Health Commission<\/strong> have issued the <strong>Guidelines for Importing Hong Kong and Macau Pharmaceuticals and Medical Devices into the Nine Mainland Cities of the Guangdong-Hong Kong-Macao Greater Bay Area<\/strong> (the &#8220;Guidelines&#8221;), which will take effect on <strong>August 8, 2026<\/strong>. This regulatory framework establishes a streamlined pathway for designated medical institutions to access urgently needed therapies already approved in Hong Kong or Macau.<\/p>\n\n\n\n<h2 id=\"h-regulatory-framework-overview\" class=\"wp-block-heading\">Regulatory Framework Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Component<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Effective Date<\/strong><\/td><td>8 Aug 2026<\/td><\/tr><tr><td><strong>Jurisdiction<\/strong><\/td><td>Nine mainland cities of Guangdong-Hong Kong-Macao Greater Bay Area<\/td><\/tr><tr><td><strong>Issuing Authorities<\/strong><\/td><td>Guangdong Provincial Drug Administration &amp; Health Commission<\/td><\/tr><tr><td><strong>Approval Validity<\/strong><\/td><td>One year from approval date<\/td><\/tr><tr><td><strong>Application Entity<\/strong><\/td><td>Designated medical institutions only<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-eligible-products\" class=\"wp-block-heading\">Eligible Products<\/h2>\n\n\n\n<h3 id=\"h-pharmaceuticals\" class=\"wp-block-heading\">Pharmaceuticals<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Drugs <strong>urgently needed for clinical use<\/strong><\/li>\n\n\n\n<li>Already <strong>marketed in Hong Kong or Macau<\/strong><\/li>\n\n\n\n<li>Imported exclusively by <strong>designated medical institutions<\/strong> in the nine mainland GBA cities<\/li>\n<\/ul>\n\n\n\n<h3 id=\"h-medical-devices\" class=\"wp-block-heading\">Medical Devices<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Devices <strong>urgently needed for clinical use<\/strong><\/li>\n\n\n\n<li><strong>Procured and used by public hospitals<\/strong> in Hong Kong or Macau<\/li>\n\n\n\n<li>Must demonstrate <strong>clinical application advancement<\/strong><\/li>\n\n\n\n<li>Imported exclusively by <strong>designated medical institutions<\/strong> in the nine mainland GBA cities<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-application-amp-review-process\" class=\"wp-block-heading\">Application &amp; Review Process<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Submission<\/strong>: Applications filed by designated medical institutions<\/li>\n\n\n\n<li><strong>Review Authority<\/strong>: Joint evaluation by Guangdong Provincial Drug Administration and Health Commission<\/li>\n\n\n\n<li><strong>Processing Timeline<\/strong>: Expedited review for urgent clinical needs<\/li>\n\n\n\n<li><strong>Post-Approval<\/strong>: One-year validity period for import and use authorization<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-market-impact-amp-strategic-implications\" class=\"wp-block-heading\">Market Impact &amp; Strategic Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Healthcare Integration<\/strong>: Accelerates cross-border healthcare harmonization within the Greater Bay Area, supporting China&#8217;s broader regional economic integration strategy<\/li>\n\n\n\n<li><strong>Patient Access<\/strong>: Provides mainland patients with faster access to innovative therapies available in Hong Kong and Macau, potentially reducing medical tourism outflows<\/li>\n\n\n\n<li><strong>Pharmaceutical Strategy<\/strong>: Creates commercial opportunities for multinational companies to leverage Hong Kong\/Macau as regulatory beachheads for mainland market entry<\/li>\n\n\n\n<li><strong>Institutional Requirements<\/strong>: Designated medical institutions must establish robust pharmacovigilance and quality control systems to maintain import privileges<\/li>\n\n\n\n<li><strong>Competitive Landscape<\/strong>: May pressure domestic manufacturers to accelerate innovation timelines or risk displacement by imported alternatives with established safety profiles<\/li>\n\n\n\n<li><strong>Regulatory Precedent<\/strong>: Could serve as a pilot program for broader cross-border medical product harmonization across other Chinese economic zones<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward-looking statements regarding regulatory implementation, market access, and competitive dynamics. Actual outcomes may differ due to risks including final operational guidelines, institutional designation criteria, and post-implementation compliance requirements.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Guangdong Provincial Drug Administration and Guangdong Provincial Health Commission have issued the Guidelines for&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[22,4],"tags":[26],"class_list":["post-70493","post","type-post","status-publish","format-standard","hentry","category-medical-device","category-policy-regulatory","tag-greater-bay-area"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Guangdong Launches Greater Bay Area Cross-Border Medical Import Framework for Hong Kong and Macau Pharmaceuticals - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"The Guangdong Provincial Drug Administration and Guangdong Provincial Health Commission have issued the Guidelines for Importing Hong Kong and Macau Pharmaceuticals and Medical Devices into the Nine Mainland Cities of the Guangdong-Hong Kong-Macao Greater Bay Area (the &quot;Guidelines&quot;), which will take effect on August 8, 2026. This regulatory framework establishes a streamlined pathway for designated medical institutions to access urgently needed therapies already approved in Hong Kong or Macau.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=70493\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Guangdong Launches Greater Bay Area Cross-Border Medical Import Framework for Hong Kong and Macau Pharmaceuticals\" \/>\n<meta property=\"og:description\" content=\"The Guangdong Provincial Drug Administration and Guangdong Provincial Health Commission have issued the Guidelines for Importing Hong Kong and Macau Pharmaceuticals and Medical Devices into the Nine Mainland Cities of the Guangdong-Hong Kong-Macao Greater Bay Area (the &quot;Guidelines&quot;), which will take effect on August 8, 2026. This regulatory framework establishes a streamlined pathway for designated medical institutions to access urgently needed therapies already approved in Hong Kong or Macau.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=70493\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-23T13:25:22+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-23T13:25:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=70493#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=70493\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Guangdong Launches Greater Bay Area Cross-Border Medical Import Framework for Hong Kong and Macau Pharmaceuticals\",\"datePublished\":\"2026-07-23T13:25:22+00:00\",\"dateModified\":\"2026-07-23T13:25:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=70493\"},\"wordCount\":386,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Greater Bay Area\"],\"articleSection\":[\"Medical Device\",\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=70493#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=70493\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=70493\",\"name\":\"Guangdong Launches Greater Bay Area Cross-Border Medical Import Framework for Hong Kong and Macau Pharmaceuticals - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-07-23T13:25:22+00:00\",\"dateModified\":\"2026-07-23T13:25:23+00:00\",\"description\":\"The Guangdong Provincial Drug Administration and Guangdong Provincial Health Commission have issued the Guidelines for Importing Hong Kong and Macau Pharmaceuticals and Medical Devices into the Nine Mainland Cities of the Guangdong-Hong Kong-Macao Greater Bay Area (the \\\"Guidelines\\\"), which will take effect on August 8, 2026. This regulatory framework establishes a streamlined pathway for designated medical institutions to access urgently needed therapies already approved in Hong Kong or Macau.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=70493#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=70493\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=70493#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Guangdong Launches Greater Bay Area Cross-Border Medical Import Framework for Hong Kong and Macau Pharmaceuticals\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Guangdong Launches Greater Bay Area Cross-Border Medical Import Framework for Hong Kong and Macau Pharmaceuticals - Insight, China&#039;s Pharmaceutical Industry","description":"The Guangdong Provincial Drug Administration and Guangdong Provincial Health Commission have issued the Guidelines for Importing Hong Kong and Macau Pharmaceuticals and Medical Devices into the Nine Mainland Cities of the Guangdong-Hong Kong-Macao Greater Bay Area (the \"Guidelines\"), which will take effect on August 8, 2026. This regulatory framework establishes a streamlined pathway for designated medical institutions to access urgently needed therapies already approved in Hong Kong or Macau.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=70493","og_locale":"en_US","og_type":"article","og_title":"Guangdong Launches Greater Bay Area Cross-Border Medical Import Framework for Hong Kong and Macau Pharmaceuticals","og_description":"The Guangdong Provincial Drug Administration and Guangdong Provincial Health Commission have issued the Guidelines for Importing Hong Kong and Macau Pharmaceuticals and Medical Devices into the Nine Mainland Cities of the Guangdong-Hong Kong-Macao Greater Bay Area (the \"Guidelines\"), which will take effect on August 8, 2026. This regulatory framework establishes a streamlined pathway for designated medical institutions to access urgently needed therapies already approved in Hong Kong or Macau.","og_url":"https:\/\/flcube.com\/?p=70493","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-07-23T13:25:22+00:00","article_modified_time":"2026-07-23T13:25:23+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=70493#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=70493"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Guangdong Launches Greater Bay Area Cross-Border Medical Import Framework for Hong Kong and Macau Pharmaceuticals","datePublished":"2026-07-23T13:25:22+00:00","dateModified":"2026-07-23T13:25:23+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=70493"},"wordCount":386,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Greater Bay Area"],"articleSection":["Medical Device","Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=70493#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=70493","url":"https:\/\/flcube.com\/?p=70493","name":"Guangdong Launches Greater Bay Area Cross-Border Medical Import Framework for Hong Kong and Macau Pharmaceuticals - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-07-23T13:25:22+00:00","dateModified":"2026-07-23T13:25:23+00:00","description":"The Guangdong Provincial Drug Administration and Guangdong Provincial Health Commission have issued the Guidelines for Importing Hong Kong and Macau Pharmaceuticals and Medical Devices into the Nine Mainland Cities of the Guangdong-Hong Kong-Macao Greater Bay Area (the \"Guidelines\"), which will take effect on August 8, 2026. This regulatory framework establishes a streamlined pathway for designated medical institutions to access urgently needed therapies already approved in Hong Kong or Macau.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=70493#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=70493"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=70493#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Guangdong Launches Greater Bay Area Cross-Border Medical Import Framework for Hong Kong and Macau Pharmaceuticals"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/70493","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=70493"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/70493\/revisions"}],"predecessor-version":[{"id":70494,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/70493\/revisions\/70494"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=70493"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=70493"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=70493"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}